Join Cell & Gene Live Chief Editor Erin Harris and panelists on May 12, 2026 at 11am ET for Distributed Manufacturing for CGT: Rent, Lease, or Buy. The discussion will cover how cell and gene therapy companies navigate the 2026 landscape marked by manufacturing overcapacity, a strategic question is no longer if to outsource, but how. Register for free today and plan to learn more!
Every clinical trial requires a constant focus on patient safety. Our medical monitoring services protect participants while securing the data integrity necessary for regulatory approval.
Simplify biosafety oversight and accelerate study startup with expert guidance that ensures NIH compliance while protecting researchers, communities, and the environment.
Our mission is grounded in urgency and purpose: to shorten the time it takes for innovative blood cancer treatments to reach the patients and families who cannot afford to wait.
Advance drug development with a CRO focused on assay validation and bioanalytical testing. We provide the precise sample prep and testing required to move your molecules to the clinic.
Accelerate your trial timelines and recruitment by reducing the administrative burden on sites. Our global network solution empowers researchers to focus on patient care and data quality.
